GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE344nnn/GSE344389/primaryOK200OtherMus musculusOtherhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE344389GEOGSEfalseBru-seq analysis of nascent transcription in IDH1-R132H mutant versus wild-type mouse glioma neurospheresMutations in isocitrate dehydrogenase 1 (IDH1-R132H) co-occur with TP53 and ATRX loss in adult low-grade glioma. Using a genetically engineered mouse glioma model (Sleeping Beauty transposon system; NRAS(G12V), shRNA-mediated Trp53 and Atrx knockdown, with or without mutant IDH1-R132H) and derived neurosphere (NS) cultures, we asked whether IDH1-R132H alters nascent transcription of DNA damage response (DDR) genes. Nascent RNA was metabolically labeled with 5-bromouridine (Bru) and Bru-labeled transcripts were immunopurified and sequenced (Bru-seq) to measure genome-wide nascent transcription rates at baseline (untreated), independent of steady-state mRNA abundance. Bru-seq identified increased nascent transcription of DDR genes, including Atm and Rad50, in IDH1-R132H-mutant (mIDH1) NS relative to wild-type IDH1 (wt-IDH1) NS, consistent with the epigenetic up-regulation of ATM signaling and enhanced DDR reported for this model.2026/08/20GSE344389GSM9978256GSM9978255GSM9978258GSM9978257GSM9978259GSM9978261GSM9978250GSM9978260GSM9978252GSM9978263GSM9978251GSM9978262GSM9978254GSM9978264GSM997825317021344389Mus musculus[42760279]